SCHEMBL9190488

SCHEMBL9190488

CCOc1ccc(/N=C/c2cc(OC)c(OC)c(OC)c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 4/20 0.65
TUBB P07437 4/20 0.65
TUBA3C P0DPH7 4/20 0.65
TUBA1B P68363 4/20 0.65
TUBA4A P68366 4/20 0.65
TUBB4B P68371 4/20 0.65
TUBB3 Q13509 4/20 0.65
TUBB2A Q13885 4/20 0.65
TUBB8 Q3ZCM7 4/20 0.65
TUBA3E Q6PEY2 4/20 0.65
TUBA1A Q71U36 4/20 0.65
TUBA1C Q9BQE3 4/20 0.65
TUBB6 Q9BUF5 4/20 0.65
TUBB2B Q9BVA1 4/20 0.65
TUBB1 Q9H4B7 4/20 0.65
PTGS2 P35354 3/20 0.58
ALDH1A1 P00352 2/20 0.54
KDM4E B2RXH2 1/20 0.54
LMNA P02545 1/20 0.54
MAPT P10636 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9190495 1.00 TUBB4A (0.65) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL8575456 0.89 PTGS2 (0.58) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL8575451 0.89 PTGS2 (0.58) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL9188784 0.86 PTGS2 (0.65) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL9188791 0.86 PTGS2 (0.65) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL9188399 0.82 TUBB1 (0.63) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL9188404 0.82 TUBB1 (0.63) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL9185811 0.80 PTGS2 (0.65) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL11692696 0.80 S100B (0.66) PTGS2ALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL11692701 0.80 S100B (0.66) PTGS2ALDH1A1KDM4EMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5430062-A Combretastatin analogues; inhibition of tubulin polymerization and colchicine binding; antitumor,-mitotic and -neoplastic agents RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1995-07-04 US disclosed
WO-1993023357-A1 STILBENE DERIVATIVES AS ANTICANCER AGENTS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1993-11-25 WO disclosed